India IVD market to reach USD 10 billion

India in vitro diagnostics market size reached USD 5.3 Billion in 2024. Looking forward, the market is expected to reach USD 10.0 Billion by 2033, exhibiting a growth rate (CAGR) of 6.84% during 2025-2033.

India in vitro diagnostics market trends and drivers:
The India in vitro diagnostics market is witnessing strong growth, underpinned by rising awareness for preventive healthcare and the growing prevalence of chronic and infectious diseases. With a rising middle-class population and enhanced access to healthcare services, demand for precise and early diagnostic solutions is building steam.

In essence, the growth of private diagnostic labs, as well as increased investment in healthcare infrastructure, is facilitating the use of IVD technologies on a large scale in urban and semi-urban areas. Furthermore, incorporation of digital technologies like cloud-based data analysis, telepathology, and AI-aided diagnostics is improving efficiency, precision, and patient outcomes.

In Addition, supportive government programs, such as public health screening initiatives and insurance for diagnostic testing, are playing an important role in expanding the market. Growth in demand for point-of-care testing, fueled by the demand for rapid and convenient diagnostics, is also transforming the sectoral dynamics.

In addition, the spread of lifestyle diseases like cardiovascular conditions and diabetes is driving the adoption of sophisticated testing solutions in the form of molecular diagnostics and immunoassays. Domestic and international players’ strategic alliances are encouraging innovation and speeding up the release of latest products in the Indian market. Overall, India In Vitro diagnostics market is transforming fast, supported by technological innovation, increasing health awareness, and the increasing significance of early disease detection. IMARC Group